Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

NCT01349712

Blood Coagulation Disorders

UNKNOWN

Blood Donation From Warfarin Users for the Development of POC INR Monitor

NCT02355730

Atrial Fibrillation Pulmonary Embolism Deep Vein Thrombosis

UNKNOWN NA

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

NCT00814177

Atrial Fibrillation Venous Thromboembolism Ischemic Stroke +1 more

COMPLETED PHASE2

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test

NCT04074980

Anticoagulants and Bleeding Disorders

COMPLETED NA

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)

NCT00933738

Coagulation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clotting Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coumadin (warfarin)

Subjects currently receiving coumadin (warfarin) treatment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are currently taking coumadin (warfarin)
* Are aged 18 years or older
* Able and willing to provide informed consent
* Can understand (read and write) English
* Required to provide a capillary sample as part of their routine medical check